Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elicio Therapeutics (ELTX) Change in Cash (2020 - 2026)

Elicio Therapeutics filings provide 4 years of Change in Cash readings, the most recent being -$2.9 million for Q4 2023.

  • On a quarterly basis, Change in Cash fell 176.06% to -$2.9 million in Q4 2023 year-over-year; TTM through Dec 2023 was $5.9 million, a 460.94% increase, with the full-year FY2025 number at -$225000.0, down 104.33% from a year prior.
  • Change in Cash hit -$2.9 million in Q4 2023 for Elicio Therapeutics, up from -$5.2 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $95.8 million in Q1 2021 to a low of -$15.8 million in Q1 2022.
  • Median Change in Cash over the past 4 years was $2.6 million (2022), compared with a mean of $5.5 million.
  • The widest YoY moves for Change in Cash: up 2190.95% in 2021, down 424.2% in 2021.
  • Elicio Therapeutics' Change in Cash stood at $20.5 million in 2020, then crashed by 168.21% to -$14.0 million in 2021, then soared by 127.22% to $3.8 million in 2022, then plummeted by 176.06% to -$2.9 million in 2023.
  • The last three reported values for Change in Cash were -$2.9 million (Q4 2023), -$5.2 million (Q3 2023), and $12.1 million (Q2 2023) per Business Quant data.